These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 26027240)
1. [X-ray, laboratory, and functional parallels in intrathoracic sarcoidosis]. Vizel IY; Vizel AA; Shaimuratov RI Ter Arkh; 2015; 87(3):48-52. PubMed ID: 26027240 [TBL] [Abstract][Full Text] [Related]
2. Optimal scoring of serial change on chest radiography in sarcoidosis. Zappala CJ; Desai SR; Copley SJ; Spagnolo R; Cramer D; Sen D; Alam SM; du Bois RM; Hansell DM; Wells AU Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):130-8. PubMed ID: 22117504 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of C-reactive protein and clinically relevant baseline variables in sarcoidosis. McDonnell MJ; Saleem MI; Wall D; Gilmartin JJ; Rutherford RM; O'Regan A Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):331-340. PubMed ID: 28079845 [TBL] [Abstract][Full Text] [Related]
4. Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data. Zappala CJ; Desai SR; Copley SJ; Spagnolo P; Sen D; Alam SM; du Bois RM; Hansell DM; Wells AU Chest; 2014 Jan; 145(1):101-107. PubMed ID: 24051950 [TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis. Keijsers RG; Verzijlbergen EJ; van den Bosch JM; Zanen P; van de Garde EM; Oyen WJ; Grutters JC Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):123-9. PubMed ID: 22117503 [TBL] [Abstract][Full Text] [Related]
6. [Dynamics of clinical, X-ray and functional data during treatment of patients with sarcoidosis]. Vizel IY; Vizel AA Klin Med (Mosk); 2017; 95(1):60-5. PubMed ID: 30299068 [TBL] [Abstract][Full Text] [Related]
7. Functional significance of the decreased attenuation sign on expiratory CT in pulmonary sarcoidosis : report of four cases. Fazzi P; Sbragia P; Solfanelli S; Troilo S; Giuntini C Chest; 2001 Apr; 119(4):1270-4. PubMed ID: 11296199 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary sarcoidosis: comparison of findings of inspiratory and expiratory high-resolution CT and pulmonary function tests between smokers and nonsmokers. Terasaki H; Fujimoto K; Müller NL; Sadohara J; Uchida M; Koga T; Aizawa H; Hayabuchi N AJR Am J Roentgenol; 2005 Aug; 185(2):333-8. PubMed ID: 16037502 [TBL] [Abstract][Full Text] [Related]
9. Opposite behavior of plasma levels surfactant protein type B and receptor for advanced glycation end products in pulmonary sarcoidosis. Magrì D; Mariotta S; Banfi C; Ricotta A; Onofri A; Ricci A; Pisani L; Cauti FM; Ghilardi S; Agostoni P Respir Med; 2013 Oct; 107(10):1617-24. PubMed ID: 23948664 [TBL] [Abstract][Full Text] [Related]
10. Exercise and resting pulmonary function in sarcoidosis. Karetzky M; McDonough M Sarcoidosis Vasc Diffuse Lung Dis; 1996 Mar; 13(1):43-9. PubMed ID: 8865409 [TBL] [Abstract][Full Text] [Related]
12. Standardized quantitative 67Ga scintigraphy in relation to carbon monoxide diffusion capacity in pulmonary sarcoidosis. Kuipers AF; Alberts C; Roos CM; van der Schoot JB; Jansen HM Sarcoidosis; 1993 Mar; 10(1):36-40. PubMed ID: 8134713 [TBL] [Abstract][Full Text] [Related]
13. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Sulica R; Teirstein AS; Kakarla S; Nemani N; Behnegar A; Padilla ML Chest; 2005 Sep; 128(3):1483-9. PubMed ID: 16162747 [TBL] [Abstract][Full Text] [Related]
14. The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients. Cameli P; Gonnelli S; Bargagli E; d'Alessandro M; Bergantini L; Favetta V; Tomai Pitinca MD; Lisi E; Refini RM; Pieroni M; Sestini P; Caffarelli C Respiration; 2020; 99(3):207-212. PubMed ID: 32114588 [TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of TGF-β/Smad and VEGF-A proteins in serum and BAL fluid of sarcoidosis patients. Piotrowski WJ; Kiszałkiewicz J; Górski P; Antczak A; Górski W; Pastuszak-Lewandoska D; Migdalska-Sęk M; Domańska-Senderowska D; Nawrot E; Czarnecka KH; Kurmanowska Z; Brzeziańska-Lasota E BMC Immunol; 2015 Oct; 16():58. PubMed ID: 26445225 [TBL] [Abstract][Full Text] [Related]
16. Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis. Mostard RL; Verschakelen JA; van Kroonenburgh MJ; Nelemans PJ; Wijnen PA; Vöö S; Drent M Respir Med; 2013 Mar; 107(3):439-47. PubMed ID: 23261309 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the modified shuttle walk test and cardiopulmonary exercise test in sarcoidosis. de Boer S; Kolbe J; Wilsher ML Respirology; 2014 May; 19(4):604-7. PubMed ID: 24666931 [TBL] [Abstract][Full Text] [Related]
18. Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity. Wallaert B; Talleu C; Wemeau-Stervinou L; Duhamel A; Robin S; Aguilaniu B Respiration; 2011; 82(6):501-8. PubMed ID: 21934275 [TBL] [Abstract][Full Text] [Related]
19. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Viskum K; Vestbo J Eur Respir J; 1993 Mar; 6(3):349-53. PubMed ID: 8472824 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme. III. Changes in serum level as an indicator of disease activity in untreated sarcoidosis. Selroos O; Grönhagen-Riska C Scand J Respir Dis; 1979 Dec; 60(6):328-36. PubMed ID: 231819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]